Stay updated on Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision stamp was updated to v3.6.3, replacing v3.6.2. This indicates a minor site update rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-07-03T23:59:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.2, replacing the previous v3.6.0, indicating a minor update to the page’s metadata.
    Difference
    0.1%
    Check dated 2026-06-26T23:23:42.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2026-06-12T16:43:58.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new revision of the page.
    Difference
    0.1%
    Check dated 2026-06-05T13:10:25.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, has been added to the page to reflect an update to the study page's content and version history; the previous revision, v3.5.3, remains in the history.
    Difference
    0.1%
    Check dated 2026-05-15T05:48:00.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page footer/release label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a general site/version update rather than a change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:24.000Z thumbnail image

Stay in the know with updates to Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.